Buyers Can't Bar Testimony In Teva Pay-For-Delay Suit
A Pennsylvania federal judge has cleared Teva Pharmaceuticals Industries Ltd. to use deposition testimony in an antitrust class action over an alleged pay-for-delay scheme for generic versions of cholesterol drug Niaspan,...To view the full article, register now.
Already a subscriber? Click here to view full article